Related Experiment Video
Updated: May 10, 2026

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
Published on: September 10, 2017
Preprogrammed, parallel on-chip immunoassay using system-level capillarity control
Sung-Jin Kim1, Sophie Paczesny, Shuichi Takayama
1Department of Mechanical Engineering, Konkuk University, Seoul, Republic of Korea.
This study introduces a new microfluidic chip for faster, less labor-intensive enzyme-linked immunosorbent assays (ELISA). The capillarity-driven device automates solution transport, significantly reducing manual steps and assay time.
Area of Science:
- Biochemistry
- Microfluidics
- Assay Development
Background:
- Conventional enzyme-linked immunosorbent assays (ELISA) are time-consuming and labor-intensive due to manual multiwell plate processing.
- There is a need for automated, efficient, and cost-effective immunoassay platforms, especially for point-of-care settings.
Purpose of the Study:
- To develop and validate a capillarity-driven on-chip immunoassay system.
- To demonstrate reduced time, labor, and pipetting steps compared to traditional ELISA.
- To achieve sensitive quantification of specific biomarkers using the microfluidic device.
Main Methods:
- Design and fabrication of a microfluidic device with integrated multiwells and detection channels.
- Utilizing passive, capillarity-driven fluid transport for sample and reagent manipulation.
- Performing multiplexed immunoassays for C-reactive protein and suppressor of tumorigenicity 2 quantification.
Main Results:
- The on-chip immunoassay successfully quantified C-reactive protein and suppressor of tumorigenicity 2 with low detection limits (8 pM and 90 pM, respectively).
- The assay completed within 30 minutes, significantly reducing processing time.
- The number of pipetting steps was reduced approximately fivefold compared to conventional multiwell plate assays.
Conclusions:
- The capillarity-driven on-chip immunoassay offers a time- and labor-saving alternative to traditional ELISA.
- This microfluidic platform is suitable for sophisticated, parallel biochemical processing in resource-limited point-of-care environments.
- The developed device demonstrates the potential for efficient and automated biomarker quantification.
More Related Videos
08:22Electrowetting-based Digital Microfluidics Platform for Automated Enzyme-linked Immunosorbent Assay
Published on: February 23, 2020
09:58Computer Numerical Control Micromilling of a Microfluidic Acrylic Device with a Staggered Restriction for Magnetic Nanoparticle-Based Immunoassays
Published on: June 23, 2022